Diane McDowell
Directeur Technique/Scientifique/R&D chez IO BIOTECH, INC.
Provenance du réseau au premier degré de Diane McDowell
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 22 | |
Weaver Co., Inc.
 Weaver Co., Inc. Engineering & ConstructionIndustrial Services Weaver Co. Inc. offers site improvement services. The firm specializes in erosion control, earthmoving, grading, paving, concrete work, sanitary sewers, water lines, all types of storm water management, soil conservation, and wetlands mitigation. The company is headquartered in Conway, SC.
1
| Private Company | Engineering & Construction | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Diane McDowell via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Treasurer | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Investor Relations Contact | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Public Communications Contact | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Investor Relations Contact | |
DiObex, Inc.
 DiObex, Inc. Pharmaceuticals: MajorHealth Technology DiObex, Inc. develops therapies for metabolic disease treatment. Its products address the markets for the treatment of diabetes and its co-morbidities such as hypertension, dyslipidemia, and visceral adiposity. The company was founded in 2003 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Founder President | |
| CODEXIS, INC. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree | |
| Bentley University | College/University | Masters Business Admin | |
| Salem International University | College/University | Undergraduate Degree | |
Symbion A/S
 Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | General Government | Corporate Officer/Principal | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member | |
Life Science Ventures
 Life Science Ventures Investment ManagersFinance Life Science Ventures provides financial advice. | Investment Managers | Corporate Officer/Principal | |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Sunstone LSV General Partner I ApS | Corporate Officer/Principal | ||
| CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
| Copenhagen Business Center | Corporate Officer/Principal | ||
| Dartmouth Medical School | College/University | Doctorate Degree | |
FBC Device ApS
 FBC Device ApS Medical SpecialtiesHealth Technology FBC Device ApS provides spinal implants for the treatment of degenerative disc disease. Its products include Statur-L. The firm develops and manufactures healthcare equipment that helps in the placement of spine in correct position after an implant surgery. The company was founded by Finn Bjarke Christensen in 2005 and is headquartered in Risskov, Denmark. | Medical Specialties | Director/Board Member | |
OncoNOx ApS
 OncoNOx ApS Pharmaceuticals: MajorHealth Technology OncoNOx ApS provides drugs for the treatment of autoimmune diseases and cancer. It is a pharmaceutical company that transforms marketed drugs into proprietary molecules with anti-cancer and/or anti-inflammatory properties. The firm's projects include OX1001 and OX27-NO is a potent anti-cancer compounds in vitro and in vivo and are intended for the treatment of cancer, and OX1001 also exhibits anti-viral activity and is in development for treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome patients with or without HIV related cancer. The company was founded by Ferdinando Nicoletti, Gianni Garotta, Yousef Al-Abed, Marco Donia, and Mai-Britt Zocca in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Founder | |
Renovaro Biosciences Denmark ApS
 Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Dandrit Biotech A/S conducts clinical research, trading, and manufacturing for the pharmaceutical industry. It focuses on research and development of medicines. The company was founded on April 1, 2001 and is headquartered in Hørsholm, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Human Resources Officer | |
| REZOLUTE, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| The International Venture Club | Corporate Officer/Principal | ||
| Sunstone LSV Management A/S | Director/Board Member | ||
| Sunstone LSV General Partner BI ApS | Corporate Officer/Principal | ||
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| Sunstone Lsv Special Ltd. Partner Iii Holding Aps | Chief Executive Officer | ||
ReWind Therapeutics NV
 ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology ReWind Therapeutics NV is a biotech company based in Leuven, Belgium that develops first-in-class remyelinating therapies for myelin-related diseases. The Belgian company's aim is to bring these therapies into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged, leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition, and movement, among others. ReWind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, optic neuritis, or nerve injuries. The company's team has extensive R&D expertise and has built a strong patent estate for developing novel remyelination therapeutics. The company was founded in 2017 by Ku Leuven's Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. The CEO of the company since 2021 is Anja Harmeier. | Pharmaceuticals: Major | Director/Board Member | |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Chairman | |
Parsimoneous Holding ApS
 Parsimoneous Holding ApS Financial ConglomeratesFinance Parsimoneous Holding ApS functions as an investment holding Danish company. The private company is based in Gentofte, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Latentix ApS
 Latentix ApS Information Technology ServicesTechnology Services Latentix ApS provides custom computer programming services. The private company is based in Frederiksberg, Denmark. | Information Technology Services | Corporate Officer/Principal | |
Sunstone Tv Lsv Special LP Ill Aps
 Sunstone Tv Lsv Special LP Ill Aps Financial ConglomeratesFinance Sunstone Tv Lsv Special LP Ill Aps is an investment holding Danish company. The private company is based in Copenhagen, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| Asbjørn Andersson ApS | Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 25 |
| Danemark | 21 |
| Suède | 3 |
| Belgique | 3 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 8 |
| Finance | 5 |
| Commercial Services | 3 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 114 |
| Corporate Officer/Principal | 42 |
| Independent Dir/Board Member | 31 |
| Chief Executive Officer | 23 |
| Chairman | 13 |
Relations les plus connectées
| Insiders | |
|---|---|
| Claus Asbjørn Andersson | 41 |
| Jack Nielsen | 38 |
| Emmanuelle Coutanceau | 21 |
| K. Hirth | 18 |
| David Smith | 17 |
| Kathleen Glaub | 13 |
| Mai-Britt Zocca | 13 |
| Devin Smith | 11 |
| Christian Ellebæk Elling | 10 |
| Priyanka Belawat | 10 |
| Vanessa Malier | 10 |
| Keith Vendola | 9 |
| Heidi Hunter | 9 |
| Helen Collins | 8 |
| Amy Sullivan | 8 |
- Bourse
- Insiders
- Diane McDowell
- Connexions Sociétés
